Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Travel Medicine · Hemorrhagic Fever with Renal Syndrome

Is There a Vaccine for HFRS? Availability Explained

At a Glance

Vaccines can help prevent hemorrhagic fever with renal syndrome, but licensed options are limited to certain high-risk areas such as South Korea and China. Most people rely on rodent control and safe cleanup because no vaccine is widely available worldwide.

Yes, there are vaccines designed to prevent hemorrhagic fever with renal syndrome (HFRS), but they are only authorized and available in a few specific countries where the disease is highly endemic, such as South Korea and China [1][2]. Currently, no HFRS vaccine is licensed for use or widely available globally, including by regulatory agencies in the United States or Europe [1][3].

Important Note on Prevention vs. Treatment:
Vaccines are exclusively used to prevent future hantavirus infections [2][4]. If you have already been diagnosed with HFRS, a vaccine will not treat the active infection, reverse acute kidney injury, or substitute for the supportive hospital care required during an active illness [2][5].

Where the Vaccine is Available

Because HFRS is caused by specific hantaviruses heavily concentrated in certain regions, vaccine authorization is limited to those high-risk areas:

  • South Korea: The Hantavax vaccine is authorized and serves as a major protection strategy, primarily for high-risk groups such as military personnel stationed near the demilitarized zone and residents in known hantavirus hotspots [1].
  • China: Inactivated HFRS vaccines are used broadly as a public health strategy in high-prevalence areas, where they have shown strong protective effects [2][6].

For a vaccine to be effective, individuals must complete the entire recommended series of doses, which may include a booster [4]. Research shows that HFRS can still occur in people who receive an incomplete vaccination series [4].

While researchers are studying experimental vaccines designed to protect against multiple hantavirus strains at once, these candidates are currently in laboratory or early testing phases and are not available to the public [7][8].

Primary Prevention: Rodent Control

Because an HFRS vaccine is not an option for most people globally, the primary strategy to prevent infection is strict rodent control [3]. Hantaviruses are typically transmitted when humans inhale airborne dust contaminated by the urine, droppings, or saliva of infected rodents [3].

Protecting yourself requires a combination of sanitation, sealing entry points to reduce rodent density, and practicing safe cleanup protocols [3][6].

Safe Cleanup Guidelines

If you must clean a rodent-infested area, strict adherence to infection-prevention practices and appropriate personal protective equipment (PPE) is critical [9][10].

  • Do not sweep or vacuum dry rodent droppings, urine, or nests, as this can launch the virus into the air you breathe.
  • Instead, follow official local public health protocols: thoroughly ventilate the space, soak the area with an appropriate wet disinfectant, and use necessary PPE (such as specific respirators and gloves) as directed by occupational or public health authorities [3][9]. Heavy infestations may require professional remediation.

Common questions in this guide

Is there a vaccine that prevents hemorrhagic fever with renal syndrome?
Yes. Vaccines to prevent hemorrhagic fever with renal syndrome are authorized and used in some endemic areas, including South Korea and China, but no vaccine is licensed or widely available worldwide, including in the United States or Europe.
Can an HFRS vaccine cure an infection I already have?
No. An HFRS vaccine is used to prevent future hantavirus infections; it does not treat active HFRS or reverse acute kidney injury, and active illness requires supportive hospital care.
Who is most likely to be offered an HFRS vaccine?
Availability and eligibility depend on local public health policy. In South Korea, Hantavax is used especially for high-risk groups such as military personnel near the demilitarized zone and people living in known hotspots; China uses inactivated vaccines in high-prevalence areas.
Does receiving only part of the HFRS vaccine series protect me?
Protection may be incomplete if you do not receive the full recommended series, which may include a booster. HFRS can still occur after incomplete vaccination, so follow the schedule provided by local health authorities.
How can I prevent HFRS if a vaccine is unavailable where I live?
Reduce contact with rodents by sealing entry points, keeping areas sanitary, and following official guidance for cleaning contaminated spaces. Do not sweep or vacuum dry droppings, urine, or nests; ventilate the area, wet it with an appropriate disinfectant, use recommended protective equipment, and ask professionals to handle heavy infestations.
Should I ask about HFRS vaccination before traveling to South Korea or China?
If you plan long-term work or travel in rural or other endemic areas, ask a travel medicine specialist about local vaccine availability and timing before you leave. Avoiding rodent exposure remains important because vaccine availability is limited and vaccination does not replace prevention measures.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since an HFRS vaccine is not available in my region, what specific occupational health or public health protocols should I follow for safe rodent cleanup?
  2. 2.Does my occupation or living environment place me at high risk for hantavirus exposure, and what steps should I take to mitigate that risk?
  3. 3.If I am planning long-term work or travel to an endemic area like South Korea or China, when and where should I consult a travel medicine specialist about hantavirus risks?
  4. 4.Who should I contact locally if I discover a heavy rodent infestation in my workplace or home?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Hemorrhagic Fever with Renal Syndrome.

    Noh JY, Jung J, Song JW

    Infection & chemotherapy 2019; (51(4)):405-413 doi:10.3947/ic.2019.51.4.405.

    PMID: 31668027
  2. 2

    The protective efficacy of inactivated vaccine against hemorrhagic fever with renal syndrome: A meta-analysis.

    Wu W, Liu J, Guo S, et al.

    Medicine 2025; (104(20)):e42463 doi:10.1097/MD.0000000000042463.

    PMID: 40388733
  3. 3

    Investigation on the Epidemic Situation of Epidemic Hemorrhagic Fever in an Island Industrial Park in Zhoushan, China.

    Tan Q, Shu J, Ye L, et al.

    Vector borne and zoonotic diseases (Larchmont, N.Y.) 2024; (24(8)):546-551 doi:10.1089/vbz.2023.0131.

    PMID: 38868950
  4. 4

    History of incomplete vaccination may associate with occurrence of hemorrhagic fever with renal syndrome with relieved clinical symptoms.

    Chen Y, Yang X, Ye F, et al.

    Journal of medical virology 2016; (88(7)):1168-72 doi:10.1002/jmv.24443.

    PMID: 26636561
  5. 5

    Kidney Diseases Associated With Parvovirus B19, Hanta, Ebola, and Dengue Virus Infection: A Brief Review.

    Prasad N, Novak JE, Patel MR

    Advances in chronic kidney disease 2019; (26(3)):207-219 doi:10.1053/j.ackd.2019.01.006.

    PMID: 31202393
  6. 6

    Changes of HFRS Incidence Caused by Vaccine Intervention in Yichun City, China, 2005-2013.

    Liu X, Zhang T, Xie C, Xie Y

    Medical science monitor : international medical journal of experimental and clinical research 2016; (22()):295-301 doi:10.12659/msm.895886.

    PMID: 26818778
  7. 7

    A comprehensive screening of the whole proteome of hantavirus and designing a multi-epitope subunit vaccine for cross-protection against hantavirus: Structural vaccinology and immunoinformatics study.

    Abdulla F, Nain Z, Hossain MM, et al.

    Microbial pathogenesis 2021; (150()):104705 doi:10.1016/j.micpath.2020.104705.

    PMID: 33352214
  8. 8

    Pre-Clinical Studies of Inactivated Polyvalent HFRS Vaccine.

    Dzagurova TK, Siniugina AA, Ishmukhametov AA, et al.

    Frontiers in cellular and infection microbiology 2020; (10()):545372 doi:10.3389/fcimb.2020.545372.

    PMID: 33251155
  9. 9

    Recurrent Occupational Hantavirus Infections Linked to Feeder Rodent Breeding Farm, Taiwan, 2022.

    Wang KC, Chang CK, Chang SF, et al.

    Emerging infectious diseases 2024; (30(8)):1702-1705 doi:10.3201/eid3008.230875.

    PMID: 39043457
  10. 10

    Adherence to infection prevention practices and associated factors among healthcare workers in Northeastern Ethiopia, following the Northern Ethiopia conflict.

    Berihun G, Gizeyiatu A, Berhanu L, et al.

    Frontiers in public health 2024; (12()):1433115 doi:10.3389/fpubh.2024.1433115.

    PMID: 39469212

This page explains HFRS vaccine availability and rodent-exposure prevention for informational purposes only and does not constitute medical advice. Contact a healthcare professional about your exposure, travel plans, or active illness.

Get notified when new evidence is published on Hemorrhagic fever-renal syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.